BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 18283201)

  • 1. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):W60-6. PubMed ID: 18283201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.
    Boutron I; Altman DG; Moher D; Schulz KF; Ravaud P;
    Ann Intern Med; 2017 Jul; 167(1):40-47. PubMed ID: 28630973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety by modifying the CONSORT statement.
    O'Connor AM; Sargeant JM; Gardner IA; Dickson JS; Torrence ME; ; Dewey CE; Dohoo IR; Evans RB; Gray JT; Greiner M; Keefe G; Lefebvre SL; Morley PS; Ramirez A; Sischo W; Smith DR; Snedeker K; Sofos J; Ward MP; Wills R
    Zoonoses Public Health; 2010 Mar; 57(2):95-104. PubMed ID: 20070653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.
    Montgomery P; Grant S; Mayo-Wilson E; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):407. PubMed ID: 30060754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety.
    O'Connor AM; Sargeant JM; Gardner IA; Dickson JS; Torrence ME; Dewey CE; Dohoo IR; Evans RB; Gray JT; Greiner M; Keefe G; Lefebvre SL; Morley PS; Ramirez A; Sischo W; Smith DR; Snedeker K; Sofos J; Ward MP; Wills R
    Prev Vet Med; 2010 Jan; 93(1):11-8. PubMed ID: 19926151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety.
    O'Connor AM; Sargeant JM; Gardner IA; Dickson JS; Torrence ME; Dewey CE; Dohoo IR; Evans RB; Gray JT; Greiner M; Keefe G; Lefebvre SL; Morley PS; Ramirez A; Sischo W; Smith DR; Snedeker K; Sofos J; Ward MP; Wills R;
    J Vet Intern Med; 2010; 24(1):57-64. PubMed ID: 20002546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    BMJ; 2020 Jun; 369():m115. PubMed ID: 32554564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.
    Gagnier JJ; Boon H; Rochon P; Moher D; Barnes J; Bombardier C;
    Ann Intern Med; 2006 Mar; 144(5):364-7. PubMed ID: 16520478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected].
    Gagnier J; Boon H; Rochon P; Barnes J; Moher D; Bombardier C;
    Explore (NY); 2006 Mar; 2(2):143-9. PubMed ID: 16781628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement.
    Juszczak E; Altman DG; Hopewell S; Schulz K
    JAMA; 2019 Apr; 321(16):1610-1620. PubMed ID: 31012939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety.
    O'Connor AM; Sargeant JM; Gardner IA; Dickson JS; Torrence ME; Dewey CE; Dohoo IR; Evans RB; Gray JT; Greiner M; Keefe G; Lefebvre SL; Morley PS; Ramirez A; Sischo W; Smith DR; Snedeker K; Sofos JN; Ward MP; Wills R;
    J Food Prot; 2010 Jan; 73(1):132-9. PubMed ID: 20051216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration.
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):112-121. PubMed ID: 28654980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better reporting of harms in randomized trials: an extension of the CONSORT statement.
    Ioannidis JP; Evans SJ; Gøtzsche PC; O'Neill RT; Altman DG; Schulz K; Moher D;
    Ann Intern Med; 2004 Nov; 141(10):781-8. PubMed ID: 15545678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the reporting of pragmatic trials: an extension of the CONSORT statement.
    Zwarenstein M; Treweek S; Gagnier JJ; Altman DG; Tunis S; Haynes B; Oxman AD; Moher D; ;
    BMJ; 2008 Nov; 337():a2390. PubMed ID: 19001484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the quality of randomized controlled trials from two leading cancer journals using the CONSORT statement.
    Süt N; Senocak M; Uysal O; Köksalan H
    Hematol Oncol Stem Cell Ther; 2008; 1(1):38-43. PubMed ID: 20063527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.
    Kahan BC; Hall SS; Beller EM; Birchenall M; Chan AW; Elbourne D; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Juszczak E; Montgomery AA
    JAMA; 2023 Dec; 330(21):2106-2114. PubMed ID: 38051324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence of trials of operative intervention to the CONSORT statement extension for non-pharmacological treatments: a comparative before and after study.
    Gray R; Sullivan M; Altman DG; Gordon-Weeks AN
    Ann R Coll Surg Engl; 2012 Sep; 94(6):388-94. PubMed ID: 22943327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.